skip to main content
Show Results with:

6 results  for Everything in this catalogue

Refined by: author: Brochet, Bruno remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Material Type:
Article
Add to My workspace

CD62L test at 2 years of natalizumab predicts progressive multifocal leukoencephalopathy

Pignolet, Béatrice et al.

Neurology. Volume 87:Number 23 (2016) -- Lippincott Williams & Wilkins

Online access

2
Material Type:
Article
Add to My workspace

Comparative efficacy of fingolimod vs natalizumab: A French multicenter observational study

Barbin, Laetitia et al.

Neurology. Volume 86:Number 8 (2016, February 26th) -- Lippincott Williams & Wilkins

Online access

3
Material Type:
Article
Add to My workspace

CD62L test at 2 years of natalizumab predicts progressive multifocal leukoencephalopathy

Pignolet, Béatrice et al.

Neurology. Volume 87:Number 23 (2016); pp 2491-2494 -- Lippincott Williams & Wilkins

Online access

4
Material Type:
Article
Add to My workspace

CD62L test at 2 years of natalizumab predicts progressive multifocal leukoencephalopathy

Pignolet, Béatrice et al.

Neurology -- Lippincott Williams & Wilkins -- Volume: 87 23; (pages 2491-2494) -- 2016

Online access

5
Material Type:
Article
Add to My workspace

Comparative efficacy of fingolimod vs natalizumab: A French multicenter observational study

Barbin, Laetitia et al.

Neurology -- Lippincott Williams & Wilkins -- Volume: 86 8; (pages 771-778) -- 2016

Online access

6
Material Type:
Article
Add to My workspace

Treating asymptomatic bacteriuria before immunosuppressive therapy during multiple sclerosis: Should we do it?

Rouzaud, Claire et al.

Multiple sclerosis and related disorders. Volume 18: (2017, November); pp 161-163 -- Elsevier Ltd

Online access

6 results  for Everything in this catalogue

Refine Search Results

Searching Remote Databases, Please Wait